Stryker

Summary

About

About Stryker

Stryker develops implants, instruments and enabling technologies across orthopaedics, surgery, neurotechnology and emergency care. Mako SmartRobotics combines patient-specific CT planning, surgeon-controlled robotic-arm guidance and AccuStop haptic boundaries for supported hip, knee, shoulder and spine applications. Mako 4 integrates the platform with Stryker’s Q Guidance tracking and display system.

In February 2026 Stryker added Mako RPS, a handheld robotic power system for total-knee procedures, through a limited market release. RPS is a separate Mako platform designed around a familiar manual power-tool form, while Mako 4 remains the multi-specialty arm-assisted system. Procedure software, compatible implants, regulatory availability and clinical claims remain specific to the selected Mako configuration and jurisdiction.

PRICE
Range 1Y
Return
High
Low
Updated

Articles

Products

Financials

  • SYK - NYSE - USD

Team

  • Kevin Lobo - Chair and Chief Executive Officer - Stryker's Mako robotic-assisted surgery platform sits within the company's orthopaedics business.
  • Dylan Crotty - Group President, Orthopaedics - Orthopaedics is the operating lane for Mako robotic-assisted joint replacement systems.

Timeline

Events

Relations

Relationships

  • Gachon University Gil Hospital

    Technology Partner - Stryker joined Gil Hospital’s smart-orthopaedics memoranda covering planned AI diagnosis, robotic surgery and rehabilitation.

  • CMR Surgical

    Partner - CMR and Stryker announced $400m preferred equity and an exclusive U.S. Versius sales alliance, subject to approvals and closing.